Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(50%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_3
6
100%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
6(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Completed3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 36 (100.0%)

Trials by Status

completed350%
active_not_recruiting117%
recruiting233%

Recent Activity

3 active trials
Showing 5 of 6
recruitingphase_3

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

NCT06901297
recruitingphase_3

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

NCT06715891
active_not_recruitingphase_3

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

NCT06284265
completedphase_3

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

NCT06263881
completedphase_3

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

NCT05364671
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06901297Phase 3

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

Recruiting
NCT06715891Phase 3

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Recruiting
NCT06284265Phase 3

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Active Not Recruiting
NCT06263881Phase 3

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

Completed
NCT05364671Phase 3

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Completed
NCT04918771Phase 3

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6